Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.345 USD | +4.33% | +18.66% | -33.29% |
Jun. 05 | Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment | DJ |
Jun. 05 | Relay Therapeutics to Collaborate With Pfizer to Evaluate Metastatic Breast Cancer Treatment | MT |
Business Summary
Number of employees: 309
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dynamo Platform
100.0
%
| 1 | 100.0 % | 26 | 100.0 % | +1,749.82% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 26 | 100.0 % | +1,749.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 17-02-28 |
Mark Murcko
FOU | Founder | 64 | 15-05-03 |
Alexis Borisy
FOU | Founder | 52 | 15-05-03 |
Thomas Catinazzo
DFI | Director of Finance/CFO | 47 | 18-03-31 |
Imogen Pryce
COO | Chief Operating Officer | - | 20-01-31 |
Ben Wolf
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Donald Bergstrom
CTO | Chief Tech/Sci/R&D Officer | 52 | 18-03-31 |
Jeanne Gray
HRO | Human Resources Officer | - | - |
Patrick Riley
PRN | Corporate Officer/Principal | - | 21-05-09 |
Brian Adams
LAW | General Counsel | 50 | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Ingram
BRD | Director/Board Member | 61 | 19-05-31 |
Linda Hill
BRD | Director/Board Member | 67 | 18-10-08 |
Jami Rubin
BRD | Director/Board Member | 60 | 19-09-30 |
Alexis Borisy
FOU | Founder | 52 | 15-05-03 |
Laura Shawver
BRD | Director/Board Member | 66 | 17-02-28 |
Mark Murcko
FOU | Founder | 64 | 15-05-03 |
Sanjiv Patel
CEO | Chief Executive Officer | 50 | 17-02-28 |
Sekar Kathiresan
BRD | Director/Board Member | 52 | 22-07-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,741,677 | 129,603,131 ( 97.64 %) | 0 | 97.64 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.29% | 935M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- RLAY Stock
- Company Relay Therapeutics, Inc.